SCHEMBL3377672

SCHEMBL3377672

CSCC(C)NC(=O)c1c(OS(=O)(=O)C(F)(F)F)cccc1C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.35
DRD3 P35462 3/20 0.35
HTR1D P28221 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HPGD P15428 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HSD17B10 Q99714 2/20 0.34
CXCR2 P25025 1/20 0.34
HTR2A P28223 1/20 0.34
TSPO P30536 1/20 0.34
GPR183 P32249 1/20 0.34
APLNR P35414 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
ALDH1A1 P00352 2/20 0.33
RAB9A P51151 1/20 0.33
DRD4 P21917 1/20 0.33
HTR5A P47898 1/20 0.33
POLB P06746 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3377677 0.91 MEN1 (0.37) DRD2DRD3HTR1DMEN1KMT2A
SCHEMBL3373446 0.90 MEN1 (0.45) DRD2DRD3HTR1DMEN1KMT2A
SCHEMBL550871 0.88 MEN1 (0.36) MEN1KMT2AHPGDKDM4EHSD17B10
SCHEMBL3379105 0.87 NPSR1 (0.40) DRD2DRD3HTR1DHPGDKDM4E
SCHEMBL3377959 0.87 MEN1 (0.39) MEN1KMT2AHPGDKDM4EHSD17B10
SCHEMBL2162429 0.85 KCNK3 (0.43) MEN1KMT2AHPGDKDM4EHSD17B10
SCHEMBL3374780 0.81 POLB (0.39) DRD2DRD3HTR1DMEN1KMT2A
SCHEMBL5929503 0.81 RXFP1 (0.36) HSD17B10HTR2ATSPOGPR183APLNR
SCHEMBL3373454 0.81 MEN1 (0.48) DRD2DRD3HTR1DMEN1KMT2A
SCHEMBL3376132 0.81 POLB (0.43) DRD2DRD3HTR1DMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 DRD2 2764/4885DRD3 2669/4885HTR1D 2541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.